Insulin has previously been shown to attenuate vasoconstrictor respons
es to pressor agonists and accelerate vascular smooth muscle relaxatio
n and vascular smooth muscle Ca2+ efflux. To further determine the rol
e of insulin in regulating vascular smooth muscle Ca2+, quiescent A7r5
cultured vascular smooth muscle cells and human vascular smooth muscl
e cells were incubated with or without 10(-7) or 10(-8) M insulin for
1 hour and then loaded with fura 2-AM; intracellular Ca2+ responses to
and rates of recovery from angiotensin II (200 nM) and arginine vasop
ressin (AVP) (10 muM) were studied fluorometrically in stirred suspens
ion. Insulin (10(-7) M) caused an increase in the peak intracellular C
a2+ response to angiotensin II (peak/baseline x 100 = 469+/-96 versus
288+/-74, P <.05) and a decrease in the peak Ca2+ response to vasopres
sin (288+/-50 versus 389+/-33, P<.025). However, insulin also caused a
marked increase in the rate of intracellular Ca2+ recovery to baselin
e after stimulation with both angiotensin II (77.3+/-13.8 versus 30.6/-6 nM/min, P<.03) and vasopressin (P<.05), such that the cumulative e
xposure to elevated intracellular Ca2+ after stimulation with either a
gonist (ie, area under the intracellular Ca2+ curve) was reduced with
insulin treatment. Insulin (10(-8)) caused small but still significant
effects on all parameters in the A7r5 cells. Insulin also caused comp
arable effects on Ca2+ recovery in the human cells hut was without sig
nificant effect on peak Ca2+ responses to AVP. It is concluded that ac
celerated removal of cytosolic Ca2+ after agonist stimulation is likel
y to contribute to insulin attenuation of vasoconstrictor responses an
d acceleration of vascular relaxation.